| 1 |
Anti-epidermal-growth-factor-receptor agents and complete responses in the treatment of advanced non-small-cell lung cancer: a meta-analysis of 17 phase III randomized controlled trials |
|
|
| Wei-Xiang Qi,Shen Fu,Qing Zhang,Xiao-Mao Guo |
|
| Current Medical Research and Opinion. 2014; : 1 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Clinical meta-analyses of targeted therapies in adenocarcinoma |
|
|
| Emilio Bria,Maria Bonomi,Sara Pilotto,Francesco Massari,Silvia Novello,Matteo Giaj Levra,Giampaolo Tortora,Giorgio Scagliotti |
|
| Targeted Oncology. 2013; 8(1): 35 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
Clinical meta-analyses of targeted therapies in adenocarcinoma |
|
|
| Bria, E. and Bonomi, M. and Pilotto, S. and Massari, F. and Novello, S. and Levra, M.G. and Tortora, G. and Scagliotti, G. |
|
| Targeted Oncology. 2013; 8(1): 35-45 |
|
| [Pubmed] [Google Scholar] |
|
| 4 |
Cetuximab-based therapy is effective in chemotherapy-naïve patients with advanced and metastatic non-small-cell lung cancer: A meta-analysis of randomized controlled trials |
|
|
| Ibrahim, E.M., Abouelkhair, K.M., Al-Masri, O.A., Chaudry, N.C., Kazkaz, G.A. |
|
| Lung. 2011; 189(3): 193-198 |
|
| [Pubmed] [Google Scholar] |
|
| 5 |
Cetuximab-based Therapy is Effective in Chemotherapy-naïve Patients with Advanced and Metastatic Non-small-cell Lung Cancer: A Meta-analysis of Randomized Controlled Trials |
|
|
| Ezzeldin M. Ibrahim,Khaled M. Abouelkhair,Osama A. Al-Masri,Najeeb C. Chaudry,Ghieth A. Kazkaz |
|
| Lung. 2011; 189(3): 193 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 6 |
Evolving Therapies and FAK Inhibitors for the Treatment of Cancer |
|
|
| Dunn, K.B., Heffler, M., Golubovskaya, V.M. |
|
| Anti-Cancer Agents in Medicinal Chemistry. 2010; 10(10): 722-734 |
|
| [Pubmed] [Google Scholar] |
|
